ProADM measurement as risk predictor in LRTI patients
An early risk assessment of lower respiratory tract infection (LRTI) patients is essential for optimizing treatment and rational resource allocation. Adrenomedullin (ADM) has a significant presence in the course of LRTI and is strongly associated with a patient’s risk of mortality and severe complications. ADM reflects a patient’s risk profile while its elevation is independent […]
